Nucleic acid testing related concept stocks, Changhong Technology, the company's wholly owned subsidiary Shenzhen Park Mingsheng Medical Instrument Co., Ltd. is currently the main for the UW Gene, Myriad Medical and other customers to provide supporting reagent kits and consumable products. Daan gene, the company has obtained "new coronavirus (2019-nCoV) nucleic acid detection kit (fluorescence PCR method)" medical device registration certificate.
The substance of the nucleic acid test is the nucleic acid of the virus. Nucleic acid test is to look for the presence of nucleic acids of foreign invading viruses in the patient's respiratory specimens, blood or feces to determine whether they are infected by the new coronavirus. And to do a good job of normalizing prevention and control we need to speed up the improvement of testing capacity, so it is indispensable to carry out nucleic acid and antibody testing.
Listed companies, according to the "Chinese People's **** and the State Company Law" Chapter IV, Section 5 of the relevant provisions, refers to the public offering of shares approved by the State Council or the State Council authorized securities management department in the stock exchange listed and traded on the stock exchange.
Stock is a certificate of ownership issued by a joint-stock company, and it is a valuable security issued by a joint-stock company to its shareholders for the purpose of raising capital as a certificate of ownership and for the purpose of obtaining dividends and bonuses.
Each share of stock represents a basic unit of ownership of the enterprise by the shareholders. Every public company issues shares.
Each share of stock of the same class represents equal ownership of the corporation. The size of each shareholder's share of ownership of the company depends on the number of shares he or she holds as a proportion of the company's total share capital.
Shares are a constituent part of the capital of a joint-stock company and can be transferred, bought and sold, and are the main long-term credit instrument of the capital market, but the company cannot be required to return its capital contribution.
China's listed companies have A shares, B shares, H shares, N shares, S shares and other distinction. This distinction is mainly based on where the stock is listed and the investors it faces.